-
Insurers, employers, taxpayers and other consumers will all be affected as drugmakers move these products to the commercial market in May. How much you'll pay depends on your health insurance.
-
A growing hospital movement aims to improve health outcomes of homeless patients with what might be considered the ultimate preventive care: providing them with a home.
-
When a case of COVID-19 morphs into the mysterious, chronic condition known as long COVID, the specialists, appointments, medications and daily need for family care can overwhelm everyone involved.
-
The woman was unresponsive, and nurses were unable to detect her breathing. A state agency report found the facility "failed to ensure residents received dignified treatment and care at end of life."
-
As the U.S. government debates whether to require higher staffing levels at nursing homes, financial records show some owners routinely push profits to sister companies while residents are neglected.
-
U.S. doctors can now choose Amjevita instead, the first of several close copies of the popular rheumatoid arthritis drug expected this year. But industry-watchers warn consumer savings may be limited.
-
Most doctors get little training in the science of obesity or how to counsel people with the disease. As a result, many patients experience stigma in the exam room.
-
Dr. Henry Marsh felt comfortable in hospitals — until he was diagnosed with advanced prostate cancer. "I was much less self-assured now that I was a patient myself," he says. His book is And Finally.
-
The new weight-loss drugs can be life-changing for people facing health conditions worsened by obesity, but price and spotty insurance coverage may keep them out of reach.
-
The World Health Organization issued the statement as the novel coronavirus, calling it an "unprecedented outbreak." Here's what we knew — and didn't know — about the virus at that time.